Eiger BioPharmaceuticals, Inc.
|
15.77 Million USD
|
74.618%
|
Nanobac Pharmaceuticals, Incorporated
|
17.62 Thousand USD
|
-22619.88%
|
SQZ Biotechnologies Company
|
21.47 Million USD
|
81.36%
|
Evofem Biosciences, Inc.
|
18.21 Million USD
|
78.025%
|
Santhera Pharmaceuticals Holding AG
|
122.95 Million USD
|
96.744%
|
Mesoblast Limited
|
5.9 Million USD
|
32.168%
|
Propanc Biopharma, Inc.
|
- USD
|
-Infinity%
|
Genus plc
|
668.8 Million USD
|
99.401%
|
VioQuest Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
CNBX Pharmaceuticals Inc.
|
410.16 Thousand USD
|
-876.063%
|
Marizyme, Inc.
|
645.81 Thousand USD
|
-519.915%
|
ContraFect Corporation
|
- USD
|
-Infinity%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
PsyBio Therapeutics Corp.
|
- USD
|
-Infinity%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
76.76 Thousand USD
|
-5115.5%
|
Intellipharmaceutics International Inc.
|
65.72 Thousand USD
|
-5990.966%
|
AXIM Biotechnologies, Inc.
|
39.51 Thousand USD
|
-10030.751%
|
MultiCell Technologies, Inc.
|
49.32 USD
|
-8117235.766%
|
Accustem Sciences Inc.
|
- USD
|
-Infinity%
|
RVL Pharmaceuticals plc
|
49.72 Million USD
|
91.948%
|
EV Biologics, Inc.
|
48.9 Thousand USD
|
-8087.055%
|
Q BioMed Inc.
|
284.35 Thousand USD
|
-1307.927%
|
Emmaus Life Sciences, Inc.
|
29.59 Million USD
|
86.473%
|
Neon Bloom, Inc.
|
- USD
|
-Infinity%
|
Mosaic ImmunoEngineering Inc.
|
- USD
|
-Infinity%
|
Biomind Labs Inc.
|
- USD
|
-Infinity%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
Pharming Group N.V.
|
245.31 Million USD
|
98.368%
|
Oncotelic Therapeutics, Inc.
|
70 Thousand USD
|
-5619.243%
|
Skye Bioscience, Inc.
|
- USD
|
-Infinity%
|
Therapeutic Solutions International, Inc.
|
98.99 Thousand USD
|
-3944.154%
|
THC Farmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arch Therapeutics, Inc.
|
75.72 Thousand USD
|
-5186.924%
|
IMV Inc.
|
- USD
|
-Infinity%
|
Acro Biomedical Co., Ltd.
|
658.5 Thousand USD
|
-507.968%
|
Curative Biotechnology, Inc.
|
- USD
|
-Infinity%
|
GB Sciences, Inc.
|
- USD
|
-Infinity%
|
Alpha Cognition Inc.
|
- USD
|
-Infinity%
|
HST Global, Inc.
|
- USD
|
-Infinity%
|
CSL Limited
|
14.69 Billion USD
|
99.973%
|
Halberd Corporation
|
999.00 USD
|
-400647.748%
|
Enzolytics Inc.
|
52.79 Thousand USD
|
-7482.904%
|
Resverlogix Corp.
|
- USD
|
-Infinity%
|
Affymax, Inc.
|
1.36 Million USD
|
-192.438%
|
SYBLEU INC
|
11.69 Thousand USD
|
-34129.395%
|
Nuo Therapeutics, Inc.
|
608.52 Thousand USD
|
-557.897%
|
argenx SE
|
1.22 Billion USD
|
99.674%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
Northwest Biotherapeutics, Inc.
|
1.93 Million USD
|
-107.219%
|
Enzon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RespireRx Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
Inhibitor Therapeutics, Inc.
|
- USD
|
-Infinity%
|
AVAX Technologies, Inc.
|
617.38 Thousand USD
|
-548.457%
|
Zenith Capital Corp.
|
- USD
|
-Infinity%
|
Genscript Biotech Corporation
|
839.52 Million USD
|
99.523%
|
Ember Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
- USD
|
-Infinity%
|
WPD Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
American Oriental Bioengineering, Inc.
|
145.09 Million USD
|
97.241%
|
Provectus Biopharmaceuticals, Inc.
|
557.71 Thousand USD
|
-617.841%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Helix BioMedix, Inc.
|
997.72 Thousand USD
|
-301.259%
|
GlobeStar Therapeutics Corporation
|
- USD
|
-Infinity%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
48.35 Million USD
|
91.72%
|
Cotinga Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
BioStem Technologies, Inc.
|
16.68 Million USD
|
76.006%
|
ONE Bio Corp.
|
52.29 Million USD
|
92.345%
|
Reve Technologies, Inc.
|
- USD
|
-Infinity%
|
Burzynski Research Institute, Inc.
|
- USD
|
-Infinity%
|
Wesana Health Holdings Inc.
|
- USD
|
-Infinity%
|
Agentix Corp.
|
- USD
|
-Infinity%
|
LadRx Corporation
|
- USD
|
-Infinity%
|
Cell Source, Inc.
|
- USD
|
-Infinity%
|
ProtoKinetix, Incorporated
|
- USD
|
-Infinity%
|
Regen BioPharma, Inc.
|
236.56 Thousand USD
|
-1592.37%
|
Regen BioPharma, Inc.
|
236.56 Thousand USD
|
-1592.37%
|
NovAccess Global Inc.
|
- USD
|
-Infinity%
|
Endonovo Therapeutics, Inc.
|
140.24 Thousand USD
|
-2754.687%
|
Itoco Inc.
|
- USD
|
-Infinity%
|
Rasna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Pathfinder Cell Therapy, Inc.
|
- USD
|
-Infinity%
|
Kadimastem Ltd
|
- USD
|
-Infinity%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
- USD
|
-Infinity%
|
CytoDyn Inc.
|
- USD
|
-Infinity%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Mobile Lads Corp.
|
- USD
|
-Infinity%
|
NanoSphere Health Sciences Inc.
|
- USD
|
-Infinity%
|
Qrons Inc.
|
- USD
|
-Infinity%
|
Alseres Pharmaceuticals, Inc.
|
473.73 Thousand USD
|
-745.095%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
Nascent Biotech, Inc.
|
- USD
|
-Infinity%
|
Rebus Holdings, Inc.
|
- USD
|
-Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
- USD
|
-Infinity%
|
International Stem Cell Corporation
|
7.78 Million USD
|
48.601%
|
Bioxytran, Inc.
|
- USD
|
-Infinity%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
- USD
|
-Infinity%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
- USD
|
-Infinity%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
13 Thousand USD
|
-30695.923%
|
Adhera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
- USD
|
-Infinity%
|
Innovation Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Neutra Corp.
|
39.53 Thousand USD
|
-10026.65%
|
Windtree Therapeutics, Inc.
|
- USD
|
-Infinity%
|
PureTech Health plc
|
3.33 Million USD
|
-20.224%
|
Coeptis Therapeutics, Inc.
|
- USD
|
-Infinity%
|
IXICO plc
|
6.66 Million USD
|
39.933%
|
IntelGenx Technologies Corp.
|
1.03 Million USD
|
-285.32%
|
Gelesis Holdings, Inc.
|
25.76 Million USD
|
84.463%
|
CSL Limited
|
14.8 Billion USD
|
99.973%
|
Cellectis S.A.
|
755 Thousand USD
|
-430.261%
|